LFTs are a panel of blood tests that help detect liver injury, cholestasis or synthetic dysfunction. Learn what each marker ...

An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...

Catch liver issues early with a simple Liver Function Test (LFT). Learn how this blood test helps detect liver damage before symptoms appear and who should get tested. The liver is one of the most ...

October marks Liver Cancer Awareness Month, an initiative that brings attention to the disease identified by NIH as the third ...

If you’re rushed to the hospital and into emergency surgery, it would be helpful if the anesthesiology team could predict whether your body will react in the way they expect. In the majority of cases, ...

A new combined test panel called Lipid Profile ALT (Cholestech Corp., Hayward, Calif.) has received an FDA waiver from Clinical Laboratory Improvement Amendments (CLIA) standards. The panel, designed ...

Elevated liver enzymes can occur for many reasons. Most often, elevated liver enzymes are temporary and resolve on their own without treatment. Occasionally, elevated liver enzymes require additional ...

A hepatitis panel is a blood test that doctors use to diagnose hepatitis. Hepatitis refers to a group of viral liver diseases, including hepatitis A, hepatitis B, and hepatitis C. The blood test will ...

A blood test looking for five specific proteins can predict metabolic dysfunction-associated steatotic liver disease, more commonly known as fatty liver disease, researchers are scheduled to report at ...

Liver enzymes can fluctuate due to factors like hormonal changes or reactions to medications. Fluctuations are often temporary, but long-term changes may indicate a condition that requires medical ...

TransMedics' Organ Care System liver perfusion device got near unanimous support for an indication in liver transplantation by an FDA advisory committee. The agency's Gastroenterology and Urology ...

May 19 (Reuters) - A panel of advisers to the U.S. Food and Drug Administration, wary of the safety of Intercept Pharmaceuticals' (ICPT.O), opens new tab oral drug for a type of fatty liver disease, ...